Health
Roche Halts Huntington’s Gene-Silencing Programs
Roche has halted its gene-silencing programs for Huntington's disease. The company is redirecting efforts towards other initiatives, as reported by STAT News.
Coverage timeline — 1 article
STAT News
ARPA-H launches bespoke gene therapy push, Lilly and Novo to promote Bridge program, and more biotech news from The Readout
2026-07-10 13:35 UTC